Abhishek Anand

Abhishek Anand
Correspondent
New Delhi
Abhishek Anand's profile:

Abhishek Anand is a Correspondent with Financial Chronicle. He covers Banking, Insurance, Mutual Fund and the FMCG sector. A graduate in Economics from the University of Delhi, Abhishek has two years of experience as a business journalist and has covered Steel, Coal, Mines and Human Resources Development in the past.

My Stories
  • Jul 13 2011, 2229

    Indian drugmaker Dr Reddy’s Labs (DRL) along with Australian biopharma company Alchemia said that the US Food and Drug Administration has approved the launch of their generic version

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.